Bacterial Infections  >>  AZD5847  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AZD5847 / AstraZeneca
NCT01516203: Phase 2a EBA Trial of AZD5847

Completed
2a
75
RoW
AZD5847, Ethambutol, isoniazid, pyrazinamide, rifampin
National Institute of Allergy and Infectious Diseases (NIAID)
Tuberculosis
12/13
12/13

Download Options